Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance

Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance

Objectives Tuberculosis (TB) remains a major global public health problem, especially with the recent emergence of multidrug-resistant TB and extensively drug-resistant TB. There has been little consideration of the extent of substandard and falsified (SF) TB medicines as drivers of resistance. We a...

Full description

Bibliographic Details
Main Authors:	Paul N Newton, Patricia Tabernero
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	BMJ Global Health
Online Access:	https://gh.bmj.com/content/8/7/e012039.full

Similar Items

Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance
by: Tabernero, P, et al.
Published: (2023)

Is neglect of self-clearance biasing TB vaccine impact estimates?
by: Richard White, et al.
Published: (2023-08-01)

The Emergence of Extensively Drug-Resistant Tuberculosis (TB): TB/HIV Coinfection, Multidrug-Resistant TB and the Resulting Public Health Threat from Extensively Drug-Resistant TB, Globally and in Canada
by: Paul E Alexander, et al.
Published: (2007-01-01)

TB or not TB?
by: Andrew Pirotte, et al.
Published: (2024-04-01)

Relationship between National TB program and prevalence of TB drug resistance in Algeria, 1965 to 2013
by: Fadila Boulahbal
Published: (2015-01-01)

Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB
by: Aline Ferreira Placeres, et al.
Published: (2023-01-01)

TB drug prices slashed for poor countries
by: Michael Hagmann

TB and poverty: the effect of rifampicin-resistant TB on household income
by: A. Ciobanu, et al.
Published: (2024-04-01)

Effectiveness of the Novel Anti-TB Bedaquiline against Drug-Resistant TB in Africa: A Systematic Review of the Literature
by: Afsatou Ndama Traoré, et al.
Published: (2022-06-01)

The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015
by: Mario C Raviglione
Published: (2007-05-01)

Prevalence of Multidrug-Resistant TB Among Smear-Positive Pulmonary TB Patients in Banadir, Somalia: A Multicenter Study
by: Dirie AMH, et al.
Published: (2022-12-01)

Prevalence of TB-related symptoms and self-reported disability among adult TB survivors
by: A.K. McDonald, et al.
Published: (2024-12-01)

Chemotherapy of TB and M/XDR-TB
by: Manoon Leechawengwongs
Published: (2009-01-01)

‘TB OR NOT TB?’: The Importance of Appropriate Screening
by: Ana Pereira Lemos, et al.
Published: (2021-03-01)

Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB
by: E.T. Abbew, et al.
Published: (2024-07-01)

This and that in TB/ST
by: Benedict, Paul K.
Published: (2024)

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
by: Malaisamy Muniyandi, et al.
Published: (2023-08-01)

Sputum availability and quality in country-level TB prevalence surveys
by: P. Papadopoulou, et al.
Published: (2024-11-01)

Prevalence of Pre-Extensively Drug-Resistant Tuberculosis (Pre XDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Center in Mumbai
by: Unnati D. Desai, et al.
Published: (2016-07-01)

Strengthening TB surveillance system in India: Way forward for improving estimates of TB incidence
by: Rinku Sharma, et al.
Published: (2011-01-01)

tb
by: Daily, Sin Chew
Published: (2014)

Prevalence of latent TB infection among childhood contacts of adults with sputum positive pulmonary TB
by: R. Swathy, et al.
Published: (2024-07-01)

Quality of the life of the TB patients
by: V. B. Zafirova, et al.
Published: (2015-04-01)

Debate - TB or XDR TB, should that be the question?
by: Andrew Black
Published: (2007-04-01)

Stark Width Data for Tb II, Tb III and Tb IV Spectral Lines
by: Milan S. Dimitrijević
Published: (2021-03-01)

Differential Expression of lncRNAs in HIV Patients with TB and HIV-TB with Anti-Retroviral Treatment
by: Victoria A. Reid, et al.
Published: (2024-07-01)

Extensively Drug-resistant Tuberculosis (XDR-TB) Raises Challenges in TB Control in Taiwan
by: Wei-Juin Su
Published: (2008-11-01)

New global plan to halt TB
by: Sheila Davey
Published: (2001-01-01)

Drug-resistant TB prevalence study in 5 health institutions in Haiti.
by: Jonathan Hoffmann, et al.
Published: (2021-01-01)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
by: Kibriti Mehari, et al.
Published: (2019-01-01)

TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi
by: Knut Lönnroth, et al.
Published: (2022-05-01)

ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS
by: I. V. Peretokina, et al.
Published: (2018-12-01)

Challenges and opportunities in drug-resistant TB
by: G H Cassell
Published: (2015-01-01)

Post-TB sequelae in adolescent pulmonary TB survivors
by: C. Cesilia, et al.
Published: (2025-01-01)

TB survivors: why curing TB is sometimes not enough
by: E. Pontali, et al.
Published: (2024-12-01)

Accelerating TB regimen development: introducing FAST-TB
by: T. Devezin, et al.
Published: (2024-11-01)

World TB Day 2016: Unite to End TB
by: Editorial Article
Published: (2016-02-01)

Innovative approach to delivery of TB Medicines: ANYWHERE MEDICINES (AWM)
by: Yatin Dholakia
Published: (2023-01-01)

Coordinated In Vitro Release of Granulysin, Perforin and IFN-γ in TB and HIV/TB Co-Infection Associated with Clinical Outcomes before and after Anti-TB Treatment
by: Nada Pitabut, et al.
Published: (2020-08-01)

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
by: Neeraj Raizada, et al.
Published: (2014-01-01)